Found: 1
Select item for more details and to access through your institution.
A Phase I trial of H-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma.
- Published in:
- 2001
- By:
- Publication type:
- journal article